← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:563 | 563 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0420 | 71285-0420-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:563 | 563 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-441 | 70092-441-76 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:563 | 563 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6377 | 72934-6377-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:563 | 563 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-30 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:563 | 563 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-286 | 70092-286-74 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:563 | 563 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:563 | 563 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6505 | 72934-6505-2 | Hydroquinone | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:564 | 564 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-161 | 82396-161-05 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:564 | 564 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:564 | 564 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-5 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:564 | 564 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:564 | 564 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-9010 | 60652-9010-1 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:564 | 564 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:564 | 564 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:564 | 564 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:564 | 564 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8000 | 71285-8000-1 | Heparin Sodium | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:564 | 564 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0419 | 72196-0419-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:564 | 564 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-108 | 70092-108-36 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:564 | 564 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6375 | 72934-6375-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:564 | 564 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:564 | 564 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-115 | 70092-115-36 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:564 | 564 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-4 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:564 | 564 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6521 | 72934-6521-2 | Hydroquinone; Hydrocortisone; Tretinoin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:565 | 565 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-03 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:565 | 565 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-1 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:565 | 565 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2081 | 71286-2081-1 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:565 | 565 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-117 | 70092-117-79 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7023 | 71285-7023-1 | Heparin Sodium | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0400 | 71285-0400-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Valine; Phenylalanine; Tryptophan | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9235 | 71266-9235-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6386 | 72934-6386-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-287 | 70092-287-35 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:565 | 565 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6515 | 72934-6515-2 | Hydroquinone; Tretinoin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:566 | 566 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5233 | 26436-5233-3 | BUTT BALM | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:566 | 566 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:566 | 566 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-2 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:566 | 566 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-900 | 71170-900-01 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:566 | 566 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:566 | 566 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:566 | 566 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-7 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:566 | 566 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-118 | 70092-118-50 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:566 | 566 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0421 | 71285-0421-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:566 | 566 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-068 | 73198-068-30 | Glutamine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:566 | 566 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:566 | 566 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6393 | 72934-6393-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:566 | 566 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:566 | 566 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-114 | 70092-114-50 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:566 | 566 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1041 | 73013-1041-1 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:566 | 566 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6516 | 72934-6516-2 | Hydroquinone; Tretinoin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:567 | 567 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5558 | 26436-5558-0 | NAD | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:567 | 567 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:567 | 567 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-1 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:567 | 567 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:567 | 567 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:567 | 567 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:567 | 567 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-4 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:567 | 567 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-290 | 70092-290-49 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:567 | 567 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0429 | 72196-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:567 | 567 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-145 | 73198-145-30 | Glutamine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:567 | 567 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:567 | 567 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6384 | 72934-6384-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:567 | 567 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9115 | 71266-9115-1 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:567 | 567 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-116 | 70092-116-75 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:567 | 567 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1030 | 73013-1030-1 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:567 | 567 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6514 | 72934-6514-2 | Hydroquinone; Tretinoin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:568 | 568 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-004 | 68985-004-91 | Phenylephrine HCl 1mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:568 | 568 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-7 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-530 | 69374-530-25 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:568 | 568 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:568 | 568 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-2 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-113 | 70092-113-79 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5101 | 26436-5101-3 | Glutamine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1053 | 73013-1053-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6376 | 72934-6376-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5035 | 71266-5035-1 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-118 | 70092-118-50 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1042 | 73013-1042-1 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:568 | 568 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6526 | 72934-6526-2 | Hydroquinone; Tretinoin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:569 | 569 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9018 | 83826-9018-5 | Timolol, Bimatoprost | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:569 | 569 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:569 | 569 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-3 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:569 | 569 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:569 | 569 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-1 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:569 | 569 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:569 | 569 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:569 | 569 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:569 | 569 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0429 | 71285-0429-1 | Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:569 | 569 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-129 | 73198-129-30 | Glutamine; Ornithine; Lysine Hydrochloride; Arginine; Citrulline | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:569 | 569 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1050 | 73013-1050-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:569 | 569 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6378 | 72934-6378-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:569 | 569 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-294 | 70092-294-74 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:569 | 569 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-290 | 70092-290-49 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:569 | 569 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1040 | 73013-1040-1 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:569 | 569 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6522 | 72934-6522-2 | Hydroquinone; Tretinoin; Hydrocortisone | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:570 | 570 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-25 | Lorazepam | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:570 | 570 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:570 | 570 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-6 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:570 | 570 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:570 | 570 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-5 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:570 | 570 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-05 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:570 | 570 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:570 | 570 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:570 | 570 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-018 | 71449-018-32 | Hydromorphone | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:570 | 570 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4587 | 72682-4587-3 | Glutathione | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:570 | 570 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1052 | 73013-1052-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:570 | 570 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6385 | 72934-6385-2 | Hydrocortisone; Hydroquinone; Tretinoin | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:570 | 570 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-686 | 70092-686-48 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:570 | 570 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5035 | 71266-5035-1 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:570 | 570 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0600 | 83863-0600-2 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:570 | 570 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-128 | 73198-128-30 | Hydroxocobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:571 | 571 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0061 | 81483-0061-0 | Lorazepam 2mg/mL. 1mL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:571 | 571 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:571 | 571 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-4 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:571 | 571 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:571 | 571 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-7 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:571 | 571 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2081 | 71286-2081-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:571 | 571 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:571 | 571 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-30 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:571 | 571 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-286 | 70092-286-74 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:571 | 571 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4520 | 72682-4520-1 | Glutathione | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:571 | 571 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4345 | 72934-4345-8 | Finasteride; Minoxidil | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:571 | 571 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-018 | 71449-018-32 | Hydromorphone | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:571 | 571 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:571 | 571 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:571 | 571 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6505 | 72934-6505-2 | Hydroquinone | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:571 | 571 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2434 | 72627-2434-2 | Hydroxocobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:572 | 572 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2504 | 72934-2504-2 | Dazinia | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:572 | 572 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:572 | 572 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:572 | 572 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:572 | 572 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-4 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:572 | 572 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2080 | 71286-2080-2 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:572 | 572 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:572 | 572 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-50 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:572 | 572 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:572 | 572 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-049 | 73198-049-30 | Glutathione | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:572 | 572 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4352 | 72934-4352-8 | Finasteride; Minoxidil | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:572 | 572 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:572 | 572 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-111 | 70092-111-48 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:572 | 572 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-293 | 70092-293-49 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:572 | 572 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6517 | 72934-6517-2 | Hydroquinone | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:572 | 572 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1541 | 72934-1541-2 | Ibuprofen; Salicylic Acid | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:573 | 573 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-505 | 65302-505-10 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:573 | 573 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:573 | 573 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:573 | 573 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:573 | 573 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:573 | 573 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:573 | 573 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:573 | 573 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:573 | 573 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-4 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:573 | 573 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-049 | 73198-049-05 | Glutathione | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:573 | 573 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4353 | 72934-4353-8 | Finasteride; Tretinoin; Minoxidil | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:573 | 573 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-117 | 70092-117-79 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:573 | 573 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:573 | 573 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1041 | 73013-1041-1 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:573 | 573 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6524 | 72934-6524-2 | Hydroquinone | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:573 | 573 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4613 | 72934-4613-9 | Ibuprofen; Terbinafine Hydrochloride; Fluconazole; Itraconazole | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:574 | 574 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-01 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:574 | 574 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:574 | 574 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:574 | 574 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:574 | 574 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:574 | 574 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:574 | 574 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5060 | 71266-5060-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:574 | 574 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0600 | 60652-0600-2 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:574 | 574 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-115 | 70092-115-36 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:574 | 574 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2402 | 72627-2402-1 | Glutathione | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:574 | 574 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2362 | 72934-2362-2 | Fluocinolone Acetonide; Niacinamide | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:574 | 574 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:574 | 574 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-687 | 70092-687-48 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:574 | 574 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1030 | 73013-1030-1 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:574 | 574 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6506 | 72934-6506-2 | Hydroquinone | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:574 | 574 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-140 | 73702-140-71 | Indomethacin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:575 | 575 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-25 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:575 | 575 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:575 | 575 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:575 | 575 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-525 | 69374-525-25 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:575 | 575 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2074 | 71286-2074-1 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:575 | 575 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:575 | 575 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:575 | 575 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:575 | 575 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-287 | 70092-287-35 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:575 | 575 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:575 | 575 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73217-006 | 73217-006-50 | Fluorouracil | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:575 | 575 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:575 | 575 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5055 | 71266-5055-2 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:575 | 575 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1042 | 73013-1042-1 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:575 | 575 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6513 | 72934-6513-2 | Hydroquinone | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:575 | 575 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-047 | 73198-047-30 | Inositol; Choline Chloride; Cyanocobalamin; Pyridoxine Hydrochloride; Methionine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:576 | 576 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-224 | 71170-224-50 | Vancomycin 2.5g added to 500mL of 0.9% Sodium Chloride | 2024-2 | valid | 0 | 2026-09-18 |